Uprifosbuvir

Uprifosbuvir is an antiviral agent. Uprifosbuvir is a NS5b inhibitor developed for the research of chronic hepatitis C virus[1].

HCV

Reference compound

Anti-infection

COVID-19-anti-virus

Infection

https://www.medchemexpress.com/uprifosbuvir.html

99.20

DMSO : 250 mg/mL (ultrasonic)

C[C@]([C@@](N(C=CC1=O)C(N1)=O)([H])O[C@@H]2CO[P@@](OC3=CC=CC=C3)(N[C@H](C)C(OC(C)C)=O)=O)([C@@H]2O)Cl

545.91

[1]Klapars A, et al. Efficient synthesis of antiviral agent uprifosbuvir enabled by new synthetic methods. Chem Sci. 2021;12(26):9031-9036.

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

http://file.medchemexpress.com/batch_PDF/HY-103487/Uprifosbuvir-DataSheet-MedChemExpress.pdf

http://file.medchemexpress.com/batch_PDF/HY-103487/Uprifosbuvir-SDS-MedChemExpress.pdf

Phase 2

1496551-77-9